ID,,setSize,enrichmentScore,NES,pvalue,qvalue,Description
R-HSA-156902,,84,-2.81E-01,-3.44E+00,2.37E-03,1.74E-02,Peptide chain elongation
R-HSA-192823,,84,-2.81E-01,-3.44E+00,2.37E-03,1.74E-02,Viral mRNA Translation
R-HSA-156842,,88,-2.64E-01,-3.25E+00,2.67E-03,1.74E-02,Eukaryotic Translation Elongation
R-HSA-2408557,,87,-2.62E-01,-3.23E+00,2.55E-03,1.74E-02,Selenocysteine synthesis
R-HSA-72764,,88,-2.52E-01,-3.09E+00,2.67E-03,1.74E-02,Eukaryotic Translation Termination
R-HSA-176814,,70,-2.66E-01,-2.90E+00,1.66E-03,1.74E-02,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins
R-HSA-73886,,80,-2.43E-01,-2.89E+00,2.13E-03,1.74E-02,Chromosome Maintenance
R-HSA-68867,,79,-2.45E-01,-2.89E+00,2.12E-03,1.74E-02,Assembly of the pre-replicative complex
R-HSA-176409,,69,-2.65E-01,-2.88E+00,1.63E-03,1.74E-02,APC/C:Cdc20 mediated degradation of mitotic proteins
R-HSA-69052,,85,-2.33E-01,-2.85E+00,2.46E-03,1.74E-02,Switching of origins to a post-replicative state
R-HSA-6784531,,51,-3.09E-01,-2.84E+00,1.06E-03,1.74E-02,tRNA processing in the nucleus
R-HSA-68949,,65,-2.69E-01,-2.83E+00,1.50E-03,1.74E-02,Orc1 removal from chromatin
R-HSA-174178,,68,-2.65E-01,-2.83E+00,1.63E-03,1.74E-02,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
R-HSA-5689603,,80,-2.37E-01,-2.82E+00,2.13E-03,1.74E-02,UCH proteinases
R-HSA-351202,,51,-3.06E-01,-2.81E+00,1.06E-03,1.74E-02,Metabolism of polyamines
R-HSA-179419,,67,-2.64E-01,-2.80E+00,1.60E-03,1.74E-02,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint
R-HSA-69017,,66,-2.64E-01,-2.79E+00,1.54E-03,1.74E-02,CDK-mediated phosphorylation and removal of Cdc6
R-HSA-174184,,66,-2.63E-01,-2.78E+00,1.54E-03,1.74E-02,Cdc20:Phospho-APC/C mediated degradation of Cyclin A
R-HSA-174143,,81,-2.27E-01,-2.71E+00,2.24E-03,1.74E-02,APC/C-mediated degradation of cell cycle proteins
R-HSA-453276,,81,-2.27E-01,-2.71E+00,2.24E-03,1.74E-02,Regulation of mitotic cell cycle
R-HSA-141424,,85,-2.22E-01,-2.71E+00,2.46E-03,1.74E-02,Amplification of signal from the kinetochores
R-HSA-141444,,85,-2.22E-01,-2.71E+00,2.46E-03,1.74E-02,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal
R-HSA-174154,,62,-2.60E-01,-2.67E+00,1.39E-03,1.74E-02,APC/C:Cdc20 mediated degradation of Securin
R-HSA-212165,,81,-2.23E-01,-2.65E+00,2.24E-03,1.74E-02,Epigenetic regulation of gene expression
R-HSA-191859,,48,-2.93E-01,-2.62E+00,9.70E-04,1.74E-02,snRNP Assembly
R-HSA-194441,,48,-2.93E-01,-2.62E+00,9.70E-04,1.74E-02,Metabolism of non-coding RNA
R-HSA-8852276,,61,-2.58E-01,-2.62E+00,1.34E-03,1.74E-02,The role of GTSE1 in G2/M progression after G2 checkpoint
R-HSA-427413,,41,-3.15E-01,-2.60E+00,1.69E-03,1.74E-02,NoRC negatively regulates rRNA expression
R-HSA-174084,,60,-2.59E-01,-2.60E+00,1.29E-03,1.74E-02,Autodegradation of Cdh1 by Cdh1:APC/C
R-HSA-159234,,38,-3.24E-01,-2.59E+00,1.52E-03,1.74E-02,Transport of Mature mRNAs Derived from Intronless Transcripts
R-HSA-350562,,45,-2.97E-01,-2.59E+00,1.79E-03,1.74E-02,Regulation of ornithine decarboxylase (ODC)
R-HSA-69190,,32,-3.52E-01,-2.56E+00,1.35E-03,1.74E-02,DNA strand elongation
R-HSA-6790901,,51,-2.76E-01,-2.54E+00,1.06E-03,1.74E-02,rRNA modification in the nucleus and cytosol
R-HSA-5250941,,44,-2.95E-01,-2.54E+00,1.75E-03,1.74E-02,Negative epigenetic regulation of rRNA expression
R-HSA-159231,,37,-3.22E-01,-2.54E+00,1.49E-03,1.74E-02,Transport of Mature mRNA Derived from an Intronless Transcript
R-HSA-72306,,89,-2.02E-01,-2.49E+00,2.70E-03,1.74E-02,tRNA processing
R-HSA-176408,,74,-2.18E-01,-2.48E+00,1.90E-03,1.74E-02,Regulation of APC/C activators between G1/S and early anaphase
R-HSA-1236975,,87,-2.00E-01,-2.46E+00,2.55E-03,1.74E-02,Antigen processing-Cross presentation
R-HSA-450408,,49,-2.70E-01,-2.46E+00,1.94E-03,1.74E-02,AUF1 (hnRNP D0) binds and destabilizes mRNA
R-HSA-180585,,47,-2.75E-01,-2.45E+00,1.88E-03,1.74E-02,Vif-mediated degradation of APOBEC3G
R-HSA-5578749,,41,-2.94E-01,-2.43E+00,1.69E-03,1.74E-02,Transcriptional regulation by small RNAs
R-HSA-73863,,25,-3.78E-01,-2.42E+00,1.11E-03,1.74E-02,RNA Polymerase I Transcription Termination
R-HSA-69601,,46,-2.72E-01,-2.41E+00,1.83E-03,1.74E-02,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A
R-HSA-69610,,46,-2.72E-01,-2.41E+00,1.83E-03,1.74E-02,p53-Independent DNA Damage Response
R-HSA-69613,,46,-2.72E-01,-2.41E+00,1.83E-03,1.74E-02,p53-Independent G1/S DNA damage checkpoint
R-HSA-69615,,60,-2.37E-01,-2.39E+00,1.29E-03,1.74E-02,G1/S DNA Damage Checkpoints
R-HSA-9735869,,33,-3.20E-01,-2.38E+00,1.35E-03,1.74E-02,SARS-CoV-1 modulates host translation machinery
R-HSA-3371453,,61,-2.34E-01,-2.37E+00,1.34E-03,1.74E-02,Regulation of HSF1-mediated heat shock response
R-HSA-69563,,59,-2.37E-01,-2.36E+00,1.28E-03,1.74E-02,p53-Dependent G1 DNA Damage Response
R-HSA-69580,,59,-2.37E-01,-2.36E+00,1.28E-03,1.74E-02,p53-Dependent G1/S DNA damage checkpoint
R-HSA-211733,,45,-2.70E-01,-2.36E+00,1.79E-03,1.74E-02,Regulation of activated PAK-2p34 by proteasome mediated degradation
R-HSA-168325,,40,-2.88E-01,-2.36E+00,1.64E-03,1.74E-02,Viral Messenger RNA Synthesis
R-HSA-177243,,33,-3.15E-01,-2.34E+00,1.35E-03,1.74E-02,Interactions of Rev with host cellular proteins
R-HSA-349425,,46,-2.63E-01,-2.32E+00,1.83E-03,1.74E-02,Autodegradation of the E3 ubiquitin ligase COP1
R-HSA-8854050,,49,-2.54E-01,-2.31E+00,1.94E-03,1.74E-02,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
R-HSA-9759194,,75,-2.02E-01,-2.30E+00,1.95E-03,1.74E-02,Nuclear events mediated by NFE2L2
R-HSA-5696399,,81,-1.93E-01,-2.30E+00,2.24E-03,1.74E-02,Global Genome Nucleotide Excision Repair (GG-NER)
R-HSA-4641258,,51,-2.49E-01,-2.29E+00,2.11E-03,1.74E-02,Degradation of DVL
R-HSA-174417,,32,-3.14E-01,-2.28E+00,1.35E-03,1.74E-02,Telomere C-strand (Lagging Strand) Synthesis
R-HSA-159230,,31,-3.18E-01,-2.28E+00,1.96E-03,1.74E-02,Transport of the SLBP Dependant Mature mRNA
R-HSA-5696394,,38,-2.84E-01,-2.27E+00,2.28E-03,1.74E-02,DNA Damage Recognition in GG-NER
R-HSA-165054,,31,-3.17E-01,-2.27E+00,1.96E-03,1.74E-02,Rev-mediated nuclear export of HIV RNA
R-HSA-70171,,59,-2.25E-01,-2.25E+00,1.28E-03,1.74E-02,Glycolysis
R-HSA-72165,,49,-2.47E-01,-2.24E+00,1.94E-03,1.74E-02,mRNA Splicing - Minor Pathway
R-HSA-75815,,47,-2.50E-01,-2.23E+00,1.88E-03,1.74E-02,Ubiquitin-dependent degradation of Cyclin D
R-HSA-1234176,,58,-2.27E-01,-2.23E+00,2.49E-03,1.74E-02,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
R-HSA-159227,,30,-3.16E-01,-2.22E+00,1.93E-03,1.74E-02,Transport of the SLBP independent Mature mRNA
R-HSA-3928662,,37,-2.81E-01,-2.22E+00,2.23E-03,1.74E-02,EPHB-mediated forward signaling
R-HSA-5678895,,55,-2.31E-01,-2.21E+00,2.31E-03,1.74E-02,Defective CFTR causes cystic fibrosis
R-HSA-8939236,,61,-2.18E-01,-2.21E+00,1.34E-03,1.74E-02,RUNX1 regulates transcription of genes involved in differentiation of HSCs
R-HSA-1236978,,42,-2.62E-01,-2.20E+00,1.70E-03,1.74E-02,Cross-presentation of soluble exogenous antigens (endosomes)
R-HSA-4085377,,31,-3.07E-01,-2.20E+00,1.96E-03,1.74E-02,SUMOylation of SUMOylation proteins
R-HSA-180746,,30,-3.11E-01,-2.19E+00,1.93E-03,1.74E-02,Nuclear import of Rev protein
R-HSA-211000,,61,-2.16E-01,-2.19E+00,1.34E-03,1.74E-02,Gene Silencing by RNA
R-HSA-73772,,26,-3.35E-01,-2.19E+00,2.27E-03,1.74E-02,RNA Polymerase I Promoter Escape
R-HSA-167152,,35,-2.86E-01,-2.19E+00,2.08E-03,1.74E-02,Formation of HIV elongation complex in the absence of HIV Tat
R-HSA-1236974,,76,-1.91E-01,-2.18E+00,1.98E-03,1.74E-02,ER-Phagosome pathway
R-HSA-5693538,,86,-1.78E-01,-2.16E+00,2.60E-03,1.74E-02,Homology Directed Repair
R-HSA-168271,,28,-3.18E-01,-2.16E+00,1.21E-03,1.74E-02,Transport of Ribonucleoproteins into the Host Nucleus
R-HSA-4615885,,42,-2.56E-01,-2.15E+00,1.70E-03,1.74E-02,SUMOylation of DNA replication proteins
R-HSA-72202,,74,-1.89E-01,-2.15E+00,1.90E-03,1.74E-02,Transport of Mature Transcript to Cytoplasm
R-HSA-168274,,28,-3.17E-01,-2.15E+00,1.21E-03,1.74E-02,Export of Viral Ribonucleoproteins from Nucleus
R-HSA-168333,,28,-3.17E-01,-2.15E+00,1.21E-03,1.74E-02,NEP/NS2 Interacts with the Cellular Export Machinery
R-HSA-157579,,58,-2.18E-01,-2.14E+00,2.49E-03,1.74E-02,Telomere Maintenance
R-HSA-167169,,33,-2.89E-01,-2.14E+00,2.69E-03,1.74E-02,HIV Transcription Elongation
R-HSA-167200,,33,-2.89E-01,-2.14E+00,2.69E-03,1.74E-02,Formation of HIV-1 elongation complex containing HIV-1 Tat
R-HSA-167246,,33,-2.89E-01,-2.14E+00,2.69E-03,1.74E-02,Tat-mediated elongation of the HIV-1 transcript
R-HSA-73762,,41,-2.57E-01,-2.12E+00,1.69E-03,1.74E-02,RNA Polymerase I Transcription Initiation
R-HSA-5693567,,80,-1.78E-01,-2.12E+00,2.13E-03,1.74E-02,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)
R-HSA-187577,,56,-2.19E-01,-2.11E+00,2.36E-03,1.74E-02,SCF(Skp2)-mediated degradation of p27/p21
R-HSA-5658442,,61,-2.07E-01,-2.10E+00,1.34E-03,1.74E-02,Regulation of RAS by GAPs
R-HSA-73864,,44,-2.38E-01,-2.06E+00,2.62E-03,1.74E-02,RNA Polymerase I Transcription
R-HSA-73854,,44,-2.38E-01,-2.06E+00,2.62E-03,1.74E-02,RNA Polymerase I Promoter Clearance
R-HSA-5250913,,42,-2.41E-01,-2.03E+00,2.55E-03,1.74E-02,Positive epigenetic regulation of rRNA expression
R-HSA-70326,,75,-1.77E-01,-2.01E+00,1.95E-03,1.74E-02,Glucose metabolism
R-HSA-3371556,,79,-1.70E-01,-2.00E+00,2.12E-03,1.74E-02,Cellular response to heat stress
R-HSA-9609690,,58,-2.03E-01,-2.00E+00,2.49E-03,1.74E-02,HCMV Early Events
R-HSA-4570464,,43,-2.34E-01,-1.98E+00,2.62E-03,1.74E-02,SUMOylation of RNA binding proteins
R-HSA-8852135,,61,-1.95E-01,-1.98E+00,2.68E-03,1.74E-02,Protein ubiquitination
R-HSA-9664407,,56,-2.03E-01,-1.96E+00,2.36E-03,1.74E-02,Parasite infection
R-HSA-9664417,,56,-2.03E-01,-1.96E+00,2.36E-03,1.74E-02,Leishmania phagocytosis
R-HSA-9664422,,56,-2.03E-01,-1.96E+00,2.36E-03,1.74E-02,FCGR3A-mediated phagocytosis
R-HSA-674695,,68,-1.83E-01,-1.96E+00,1.63E-03,1.74E-02,RNA Polymerase II Pre-transcription Events
R-HSA-8854518,,64,-1.87E-01,-1.94E+00,1.46E-03,1.74E-02,AURKA Activation by TPX2
R-HSA-975956,,90,-2.41E-01,-2.98E+00,2.78E-03,1.77E-02,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)
R-HSA-72695,,47,-2.31E-01,-2.06E+00,2.82E-03,1.78E-02,"Formation of the ternary complex, and subsequently, the 43S complex"
R-HSA-8939902,,63,-1.87E-01,-1.93E+00,2.84E-03,1.78E-02,Regulation of RUNX2 expression and activity
R-HSA-9633012,,95,-2.71E-01,-3.47E+00,3.03E-03,1.79E-02,Response of EIF2AK4 (GCN2) to amino acid deficiency
R-HSA-72689,,95,-2.61E-01,-3.34E+00,3.03E-03,1.79E-02,Formation of a pool of free 40S subunits
R-HSA-69002,,95,-2.42E-01,-3.10E+00,3.03E-03,1.79E-02,DNA Replication Pre-Initiation
R-HSA-9648025,,96,-1.93E-01,-2.49E+00,3.01E-03,1.79E-02,EML4 and NUDC in mitotic spindle formation
R-HSA-5362768,,50,-2.33E-01,-2.12E+00,3.03E-03,1.79E-02,Hh mutants are degraded by ERAD
R-HSA-9604323,,50,-2.31E-01,-2.10E+00,3.03E-03,1.79E-02,Negative regulation of NOTCH4 signaling
R-HSA-69541,,51,-2.43E-01,-2.24E+00,3.17E-03,1.84E-02,Stabilization of p53
R-HSA-8941858,,52,-2.10E-01,-1.95E+00,3.18E-03,1.84E-02,Regulation of RUNX3 expression and activity
R-HSA-5387390,,51,-2.12E-01,-1.95E+00,3.17E-03,1.84E-02,Hh mutants abrogate ligand secretion
R-HSA-174411,,24,-3.44E-01,-2.15E+00,3.27E-03,1.88E-02,Polymerase switching on the C-strand of the telomere
R-HSA-2408522,,100,-2.40E-01,-3.10E+00,3.31E-03,1.88E-02,Selenoamino acid metabolism
R-HSA-69618,,101,-2.07E-01,-2.70E+00,3.38E-03,1.91E-02,Mitotic Spindle Checkpoint
R-HSA-156827,,104,-2.43E-01,-3.20E+00,3.57E-03,1.94E-02,L13a-mediated translational silencing of Ceruloplasmin expression
R-HSA-2500257,,104,-2.24E-01,-2.96E+00,3.57E-03,1.94E-02,Resolution of Sister Chromatid Cohesion
R-HSA-9754678,,45,-2.26E-01,-1.97E+00,3.57E-03,1.94E-02,SARS-CoV-2 modulates host translation machinery
R-HSA-72706,,105,-2.28E-01,-3.01E+00,3.66E-03,1.96E-02,GTP hydrolysis and joining of the 60S ribosomal subunit
R-HSA-5696398,,107,-1.79E-01,-2.40E+00,3.72E-03,1.96E-02,Nucleotide Excision Repair
R-HSA-606279,,23,-3.29E-01,-2.01E+00,3.73E-03,1.96E-02,Deposition of new CENPA-containing nucleosomes at the centromere
R-HSA-774815,,23,-3.29E-01,-2.01E+00,3.73E-03,1.96E-02,Nucleosome assembly
R-HSA-167172,,58,-1.98E-01,-1.95E+00,3.74E-03,1.96E-02,Transcription of the HIV genome
R-HSA-1799339,,106,-2.17E-01,-2.86E+00,3.85E-03,1.98E-02,SRP-dependent cotranslational protein targeting to membrane
R-HSA-927802,,108,-2.02E-01,-2.72E+00,3.91E-03,1.98E-02,Nonsense-Mediated Decay (NMD)
R-HSA-975957,,108,-2.02E-01,-2.72E+00,3.91E-03,1.98E-02,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)
R-HSA-179409,,25,-3.22E-01,-2.07E+00,3.89E-03,1.98E-02,APC-Cdc20 mediated degradation of Nek2A
R-HSA-180910,,30,-2.90E-01,-2.04E+00,3.85E-03,1.98E-02,Vpr-mediated nuclear import of PICs
R-HSA-68962,,32,-2.83E-01,-2.06E+00,4.04E-03,1.99E-02,Activation of the pre-replicative complex
R-HSA-6796648,,50,-2.10E-01,-1.91E+00,4.04E-03,1.99E-02,TP53 Regulates Transcription of DNA Repair Genes
R-HSA-4641257,,50,-2.08E-01,-1.89E+00,4.04E-03,1.99E-02,Degradation of AXIN
R-HSA-174113,,50,-2.02E-01,-1.84E+00,4.04E-03,1.99E-02,SCF-beta-TrCP mediated degradation of Emi1
R-HSA-69239,,114,-2.39E-01,-3.36E+00,4.20E-03,2.05E-02,Synthesis of DNA
R-HSA-72613,,112,-2.22E-01,-3.05E+00,4.29E-03,2.06E-02,Eukaryotic Translation Initiation
R-HSA-72737,,112,-2.22E-01,-3.05E+00,4.29E-03,2.06E-02,Cap-dependent Translation Initiation
R-HSA-162599,,116,-1.96E-01,-2.79E+00,4.41E-03,2.07E-02,Late Phase of HIV Life Cycle
R-HSA-72662,,54,-2.19E-01,-2.08E+00,4.47E-03,2.07E-02,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S"
R-HSA-72649,,53,-2.15E-01,-2.01E+00,4.42E-03,2.07E-02,Translation initiation complex formation
R-HSA-450531,,81,-1.63E-01,-1.95E+00,4.47E-03,2.07E-02,Regulation of mRNA stability by proteins that bind AU-rich elements
R-HSA-180786,,45,-2.20E-01,-1.92E+00,4.47E-03,2.07E-02,Extension of Telomeres
R-HSA-73884,,45,-2.19E-01,-1.91E+00,4.47E-03,2.07E-02,Base Excision Repair
R-HSA-5663220,,118,-1.82E-01,-2.60E+00,4.59E-03,2.10E-02,RHO GTPases Activate Formins
R-HSA-162909,,118,-1.80E-01,-2.57E+00,4.59E-03,2.10E-02,Host Interactions of HIV factors
R-HSA-69306,,120,-2.52E-01,-3.64E+00,4.63E-03,2.10E-02,DNA Replication
R-HSA-112382,,47,-2.18E-01,-1.94E+00,4.69E-03,2.11E-02,Formation of RNA Pol II elongation complex 
R-HSA-75955,,47,-2.18E-01,-1.94E+00,4.69E-03,2.11E-02,RNA Polymerase II Transcription Elongation
R-HSA-69481,,117,-2.23E-01,-3.14E+00,4.74E-03,2.12E-02,G2/M Checkpoints
R-HSA-169911,,48,-2.17E-01,-1.94E+00,4.85E-03,2.15E-02,Regulation of Apoptosis
R-HSA-69206,,124,-1.53E-01,-2.21E+00,5.05E-03,2.21E-02,G1/S Transition
R-HSA-168273,,127,-2.48E-01,-3.74E+00,5.15E-03,2.24E-02,Influenza Viral RNA Transcription and Replication
R-HSA-2995410,,60,-1.89E-01,-1.90E+00,5.17E-03,2.24E-02,Nuclear Envelope (NE) Reassembly
R-HSA-162587,,129,-1.83E-01,-2.79E+00,5.41E-03,2.32E-02,HIV Life Cycle
R-HSA-72702,,53,-2.14E-01,-1.99E+00,5.52E-03,2.32E-02,Ribosomal scanning and start codon recognition
R-HSA-5693607,,53,-2.12E-01,-1.98E+00,5.52E-03,2.32E-02,Processing of DNA double-strand break ends
R-HSA-389958,,21,-3.31E-01,-1.93E+00,5.52E-03,2.32E-02,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding
R-HSA-5368287,,90,-1.53E-01,-1.90E+00,5.56E-03,2.33E-02,Mitochondrial translation
R-HSA-8866652,,29,-2.90E-01,-2.00E+00,5.64E-03,2.35E-02,Synthesis of active ubiquitin: roles of E1 and E2 enzymes
R-HSA-113418,,27,-2.92E-01,-1.94E+00,5.82E-03,2.39E-02,Formation of the Early Elongation Complex
R-HSA-167158,,27,-2.92E-01,-1.94E+00,5.82E-03,2.39E-02,Formation of the HIV-1 Early Elongation Complex
R-HSA-6781827,,75,-1.70E-01,-1.94E+00,5.84E-03,2.39E-02,Transcription-Coupled Nucleotide Excision Repair (TC-NER)
R-HSA-170822,,26,-3.06E-01,-2.00E+00,6.25E-03,2.51E-02,Regulation of Glucokinase by Glucokinase Regulatory Protein
R-HSA-5619107,,26,-3.06E-01,-2.00E+00,6.25E-03,2.51E-02,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)
R-HSA-2424491,,26,-3.02E-01,-1.98E+00,6.25E-03,2.51E-02,DAP12 signaling
R-HSA-429914,,45,-2.15E-01,-1.87E+00,6.26E-03,2.51E-02,Deadenylation-dependent mRNA decay
R-HSA-9711097,,139,-1.51E-01,-2.38E+00,6.37E-03,2.54E-02,Cellular response to starvation
R-HSA-453279,,142,-1.32E-01,-2.11E+00,6.71E-03,2.59E-02,Mitotic G1 phase and G1/S transition
R-HSA-5610785,,54,-2.01E-01,-1.91E+00,6.70E-03,2.59E-02,GLI3 is processed to GLI3R by the proteasome
R-HSA-5358346,,54,-1.99E-01,-1.90E+00,6.70E-03,2.59E-02,Hedgehog ligand biogenesis
R-HSA-380259,,61,-1.80E-01,-1.82E+00,6.71E-03,2.59E-02,Loss of Nlp from mitotic centrosomes
R-HSA-380284,,61,-1.80E-01,-1.82E+00,6.71E-03,2.59E-02,Loss of proteins required for interphase microtubule organization from the centrosome
R-HSA-168255,,144,-2.28E-01,-3.68E+00,6.99E-03,2.68E-02,Influenza Infection
R-HSA-5368286,,84,-1.47E-01,-1.79E+00,7.11E-03,2.68E-02,Mitochondrial translation initiation
R-HSA-5389840,,84,-1.47E-01,-1.79E+00,7.11E-03,2.68E-02,Mitochondrial translation elongation
R-HSA-5419276,,84,-1.46E-01,-1.79E+00,7.11E-03,2.68E-02,Mitochondrial translation termination
R-HSA-5689880,,149,-1.06E-01,-1.76E+00,7.35E-03,2.73E-02,Ub-specific processing proteases
R-HSA-9762114,,49,-2.00E-01,-1.82E+00,7.75E-03,2.83E-02,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2
R-HSA-168276,,36,-2.51E-01,-1.95E+00,7.91E-03,2.88E-02,NS1 Mediated Effects on Host Pathways
R-HSA-176187,,33,-2.61E-01,-1.94E+00,8.08E-03,2.92E-02,Activation of ATR in response to replication stress
R-HSA-380320,,77,-1.61E-01,-1.85E+00,8.10E-03,2.92E-02,Recruitment of NuMA to mitotic centrosomes
R-HSA-9010553,,151,-1.66E-01,-2.74E+00,8.33E-03,2.98E-02,Regulation of expression of SLITs and ROBOs
R-HSA-5693532,,114,-1.41E-01,-1.99E+00,8.40E-03,2.98E-02,DNA Double-Strand Break Repair
R-HSA-9609646,,78,-1.60E-01,-1.86E+00,8.39E-03,2.98E-02,HCMV Infection
R-HSA-1234174,,65,-1.75E-01,-1.84E+00,9.00E-03,3.16E-02,Cellular response to hypoxia
R-HSA-73933,,38,-2.35E-01,-1.88E+00,9.10E-03,3.19E-02,Resolution of Abasic Sites (AP sites)
R-HSA-69242,,154,-1.68E-01,-2.80E+00,9.26E-03,3.22E-02,S Phase
R-HSA-69186,,20,-3.29E-01,-1.86E+00,9.88E-03,3.41E-02,Lagging Strand Synthesis
R-HSA-6803529,,26,-2.81E-01,-1.84E+00,1.02E-02,3.49E-02,FGFR2 alternative splicing
R-HSA-2467813,,163,-2.06E-01,-3.48E+00,1.06E-02,3.54E-02,Separation of Sister Chromatids
R-HSA-9615933,,25,-2.92E-01,-1.87E+00,1.05E-02,3.54E-02,Postmitotic nuclear pore complex (NPC) reformation
R-HSA-6781823,,51,-1.93E-01,-1.78E+00,1.06E-02,3.54E-02,Formation of TC-NER Pre-Incision Complex
R-HSA-69275,,166,-1.34E-01,-2.27E+00,1.08E-02,3.55E-02,G2/M Transition
R-HSA-9705683,,166,-1.04E-01,-1.76E+00,1.08E-02,3.55E-02,SARS-CoV-2-host interactions
R-HSA-9610379,,46,-2.02E-01,-1.79E+00,1.10E-02,3.61E-02,HCMV Late Events
R-HSA-174048,,23,-2.98E-01,-1.82E+00,1.12E-02,3.66E-02,APC/C:Cdc20 mediated degradation of Cyclin B
R-HSA-5687128,,74,-1.62E-01,-1.84E+00,1.14E-02,3.70E-02,MAPK6/MAPK4 signaling
R-HSA-3214858,,28,-2.71E-01,-1.83E+00,1.15E-02,3.70E-02,RMTs methylate histone arginines
R-HSA-3247509,,167,-9.99E-02,-1.70E+00,1.15E-02,3.70E-02,Chromatin modifying enzymes
R-HSA-4839726,,167,-9.99E-02,-1.70E+00,1.15E-02,3.70E-02,Chromatin organization
R-HSA-9013407,,34,-2.49E-01,-1.87E+00,1.18E-02,3.78E-02,RHOH GTPase cycle
R-HSA-210991,,19,-3.35E-01,-1.86E+00,1.19E-02,3.79E-02,Basigin interactions
R-HSA-159236,,65,-1.70E-01,-1.79E+00,1.20E-02,3.80E-02,Transport of Mature mRNA derived from an Intron-Containing Transcript
R-HSA-110373,,25,-2.88E-01,-1.85E+00,1.22E-02,3.86E-02,Resolution of AP sites via the multiple-nucleotide patch replacement pathway
R-HSA-389957,,20,-3.24E-01,-1.83E+00,1.23E-02,3.88E-02,Prefoldin mediated transfer of substrate  to CCT/TriC
R-HSA-6791226,,168,-2.60E-01,-4.38E+00,1.27E-02,3.95E-02,Major pathway of rRNA processing in the nucleolus and cytosol
R-HSA-453274,,168,-1.36E-01,-2.30E+00,1.27E-02,3.95E-02,Mitotic G2-G2/M phases
R-HSA-69205,,27,-2.68E-01,-1.78E+00,1.34E-02,4.15E-02,G1/S-Specific Transcription
R-HSA-8868773,,176,-2.54E-01,-4.55E+00,1.35E-02,4.18E-02,rRNA processing in the nucleus and cytosol
R-HSA-76046,,36,-2.37E-01,-1.84E+00,1.37E-02,4.21E-02,RNA Polymerase III Transcription Initiation
R-HSA-72163,,175,-1.86E-01,-3.27E+00,1.39E-02,4.24E-02,mRNA Splicing - Major Pathway
R-HSA-1169091,,62,-1.69E-01,-1.73E+00,1.39E-02,4.24E-02,Activation of NF-kappaB in B cells
R-HSA-180534,,47,-1.92E-01,-1.71E+00,1.41E-02,4.27E-02,Vpu mediated degradation of CD4
R-HSA-1268020,,50,-1.88E-01,-1.71E+00,1.41E-02,4.27E-02,Mitochondrial protein import
R-HSA-68877,,174,-1.64E-01,-2.84E+00,1.43E-02,4.29E-02,Mitotic Prometaphase
R-HSA-3232142,,34,-2.44E-01,-1.84E+00,1.46E-02,4.36E-02,SUMOylation of ubiquitinylation proteins
R-HSA-72312,,181,-2.40E-01,-4.36E+00,1.54E-02,4.56E-02,rRNA processing
R-HSA-5250924,,28,-2.61E-01,-1.77E+00,1.58E-02,4.62E-02,B-WICH complex positively regulates rRNA expression
R-HSA-72172,,183,-1.76E-01,-3.14E+00,1.59E-02,4.64E-02,mRNA Splicing
R-HSA-198933,,74,-1.54E-01,-1.76E+00,1.71E-02,4.97E-02,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
R-HSA-1433559,,15,-3.66E-01,-1.80E+00,1.77E-02,5.13E-02,Regulation of KIT signaling
R-HSA-5693579,,35,-2.31E-01,-1.77E+00,1.80E-02,5.20E-02,Homologous DNA Pairing and Strand Exchange
R-HSA-9755511,,94,-1.28E-01,-1.62E+00,1.82E-02,5.23E-02,KEAP1-NFE2L2 pathway
R-HSA-5610780,,53,-1.80E-01,-1.68E+00,1.99E-02,5.61E-02,Degradation of GLI1 by the proteasome
R-HSA-141405,,20,-3.03E-01,-1.71E+00,2.07E-02,5.79E-02,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components
R-HSA-141430,,20,-3.03E-01,-1.71E+00,2.07E-02,5.79E-02,Inactivation of APC/C via direct inhibition of the APC/C complex
R-HSA-376176,,194,-1.51E-01,-2.80E+00,2.08E-02,5.79E-02,Signaling by ROBO receptors
R-HSA-5610783,,54,-1.77E-01,-1.68E+00,2.12E-02,5.86E-02,Degradation of GLI2 by the proteasome
R-HSA-983705,,105,-1.30E-01,-1.71E+00,2.20E-02,5.97E-02,Signaling by the B Cell Receptor (BCR)
R-HSA-6782210,,62,-1.62E-01,-1.66E+00,2.22E-02,5.99E-02,Gap-filling DNA repair synthesis and ligation in TC-NER
R-HSA-512988,,41,-2.08E-01,-1.72E+00,2.28E-02,6.00E-02,"Interleukin-3, Interleukin-5 and GM-CSF signaling"
R-HSA-6807505,,67,-1.60E-01,-1.71E+00,2.24E-02,6.00E-02,RNA polymerase II transcribes snRNA genes
R-HSA-1538133,,25,-2.63E-01,-1.69E+00,2.28E-02,6.00E-02,G0 and Early G1
R-HSA-167287,,25,-2.63E-01,-1.69E+00,2.28E-02,6.00E-02,HIV elongation arrest and recovery
R-HSA-167290,,25,-2.63E-01,-1.69E+00,2.28E-02,6.00E-02,Pausing and recovery of HIV elongation
R-HSA-380270,,72,-1.51E-01,-1.69E+00,2.39E-02,6.23E-02,Recruitment of mitotic centrosome proteins and complexes
R-HSA-380287,,72,-1.51E-01,-1.69E+00,2.39E-02,6.23E-02,Centrosome maturation
R-HSA-9013694,,76,-1.51E-01,-1.72E+00,2.57E-02,6.62E-02,Signaling by NOTCH4
R-HSA-69473,,50,-1.81E-01,-1.65E+00,2.63E-02,6.73E-02,G2/M DNA damage checkpoint
R-HSA-5685942,,55,-1.71E-01,-1.63E+00,2.78E-02,7.02E-02,HDR through Homologous Recombination (HRR)
R-HSA-9675136,,33,-2.24E-01,-1.66E+00,2.83E-02,7.09E-02,Diseases of DNA Double-Strand Break Repair
R-HSA-9701190,,33,-2.24E-01,-1.66E+00,2.83E-02,7.09E-02,Defective homologous recombination repair (HRR) due to BRCA2 loss of function
R-HSA-190828,,24,-2.65E-01,-1.66E+00,2.84E-02,7.09E-02,Gap junction trafficking
R-HSA-72086,,27,-2.47E-01,-1.64E+00,2.85E-02,7.10E-02,mRNA Capping
R-HSA-176033,,32,-2.29E-01,-1.66E+00,2.90E-02,7.19E-02,Interactions of Vpr with host cellular proteins
R-HSA-389960,,15,-3.42E-01,-1.68E+00,2.96E-02,7.34E-02,Formation of tubulin folding intermediates by CCT/TriC
R-HSA-8953750,,33,-2.19E-01,-1.62E+00,3.03E-02,7.45E-02,Transcriptional Regulation by E2F6
R-HSA-75067,,29,-2.42E-01,-1.67E+00,3.07E-02,7.50E-02,Processing of Capped Intronless Pre-mRNA
R-HSA-3301854,,32,-2.20E-01,-1.60E+00,3.50E-02,8.42E-02,Nuclear Pore Complex (NPC) Disassembly
R-HSA-5693616,,32,-2.19E-01,-1.59E+00,3.50E-02,8.42E-02,Presynaptic phase of homologous DNA pairing and strand exchange
R-HSA-76071,,28,-2.38E-01,-1.61E+00,3.94E-02,9.35E-02,RNA Polymerase III Transcription Initiation From Type 3 Promoter
R-HSA-176412,,19,-2.84E-01,-1.58E+00,3.95E-02,9.35E-02,Phosphorylation of the APC/C
R-HSA-9646399,,29,-2.33E-01,-1.61E+00,4.01E-02,9.37E-02,Aggrephagy
R-HSA-157858,,26,-2.43E-01,-1.59E+00,4.03E-02,9.37E-02,Gap junction trafficking and regulation
R-HSA-167238,,23,-2.59E-01,-1.58E+00,4.05E-02,9.37E-02,Pausing and recovery of Tat-mediated HIV elongation
R-HSA-167243,,23,-2.59E-01,-1.58E+00,4.05E-02,9.37E-02,Tat-mediated HIV elongation arrest and recovery
R-HSA-9687136,,19,-2.84E-01,-1.58E+00,4.05E-02,9.37E-02,Aberrant regulation of mitotic exit in cancer due to RB1 defects
R-HSA-5619084,,64,-1.51E-01,-1.56E+00,4.08E-02,9.42E-02,ABC transporter disorders
R-HSA-5218859,,49,-1.68E-01,-1.53E+00,4.26E-02,9.75E-02,Regulated Necrosis
R-HSA-2172127,,32,-2.12E-01,-1.54E+00,4.38E-02,9.98E-02,DAP12 interactions
R-HSA-4551638,,52,-1.66E-01,-1.54E+00,4.46E-02,1.01E-01,SUMOylation of chromatin organization proteins
R-HSA-69656,,80,-1.29E-01,-1.53E+00,4.47E-02,1.01E-01,Cyclin A:Cdk2-associated events at S phase entry
R-HSA-9705671,,96,-1.18E-01,-1.52E+00,4.52E-02,1.01E-01,SARS-CoV-2 activates/modulates innate and adaptive immune responses
R-HSA-73856,,63,-1.49E-01,-1.54E+00,4.54E-02,1.01E-01,RNA Polymerase II Transcription Termination
R-HSA-975163,,15,-3.21E-01,-1.58E+00,4.61E-02,1.02E-01,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation
R-HSA-5651801,,21,-2.69E-01,-1.57E+00,4.61E-02,1.02E-01,PCNA-Dependent Long Patch Base Excision Repair
R-HSA-5693554,,21,-2.69E-01,-1.57E+00,4.66E-02,1.03E-01,Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)
R-HSA-69273,,21,-2.69E-01,-1.56E+00,4.71E-02,1.03E-01,Cyclin A/B1/B2 associated events during G2/M transition
R-HSA-3214841,,31,-2.19E-01,-1.57E+00,4.91E-02,1.06E-01,PKMTs methylate histone lysines
R-HSA-167242,,19,-2.77E-01,-1.54E+00,5.05E-02,1.09E-01,Abortive elongation of HIV-1 transcript in the absence of Tat
R-HSA-167161,,43,-1.81E-01,-1.54E+00,5.15E-02,1.09E-01,HIV Transcription Initiation
R-HSA-167162,,43,-1.81E-01,-1.54E+00,5.15E-02,1.09E-01,RNA Polymerase II HIV Promoter Escape
R-HSA-73776,,43,-1.81E-01,-1.54E+00,5.15E-02,1.09E-01,RNA Polymerase II Promoter Escape
R-HSA-73779,,43,-1.81E-01,-1.54E+00,5.15E-02,1.09E-01,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
R-HSA-75953,,43,-1.81E-01,-1.54E+00,5.15E-02,1.09E-01,RNA Polymerase II Transcription Initiation
R-HSA-76042,,43,-1.81E-01,-1.54E+00,5.15E-02,1.09E-01,RNA Polymerase II Transcription Initiation And Promoter Clearance
R-HSA-202403,,108,-1.12E-01,-1.51E+00,5.08E-02,1.09E-01,TCR signaling
R-HSA-5620971,,22,-2.60E-01,-1.55E+00,5.22E-02,1.10E-01,Pyroptosis
R-HSA-2980766,,48,-1.65E-01,-1.48E+00,5.33E-02,1.12E-01,Nuclear Envelope Breakdown
R-HSA-1168372,,78,-1.31E-01,-1.52E+00,5.45E-02,1.14E-01,Downstream signaling events of B Cell Receptor (BCR)
R-HSA-6783310,,31,-2.14E-01,-1.53E+00,5.62E-02,1.17E-01,Fanconi Anemia Pathway
R-HSA-5626467,,22,-2.55E-01,-1.52E+00,5.83E-02,1.21E-01,RHO GTPases activate IQGAPs
R-HSA-5693537,,25,-2.34E-01,-1.50E+00,6.05E-02,1.24E-01,Resolution of D-Loop Structures
R-HSA-5693568,,25,-2.34E-01,-1.50E+00,6.05E-02,1.24E-01,Resolution of D-loop Structures through Holliday Junction Intermediates
R-HSA-69202,,78,-1.27E-01,-1.48E+00,6.08E-02,1.24E-01,Cyclin E associated events during G1/S transition 
R-HSA-2029482,,58,-1.50E-01,-1.48E+00,6.11E-02,1.25E-01,Regulation of actin dynamics for phagocytic cup formation
R-HSA-69183,,15,-3.09E-01,-1.52E+00,6.17E-02,1.25E-01,Processive synthesis on the lagging strand
R-HSA-167160,,25,-2.29E-01,-1.47E+00,6.72E-02,1.35E-01,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
R-HSA-77075,,25,-2.29E-01,-1.47E+00,6.72E-02,1.35E-01,RNA Pol II CTD phosphorylation and interaction with CE
R-HSA-5617472,,48,-1.60E-01,-1.43E+00,6.79E-02,1.35E-01,Activation of anterior HOX genes in hindbrain development during early embryogenesis
R-HSA-5619507,,48,-1.60E-01,-1.43E+00,6.79E-02,1.35E-01,Activation of HOX genes during differentiation
R-HSA-176407,,19,-2.65E-01,-1.47E+00,6.85E-02,1.36E-01,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
R-HSA-9664323,,34,-1.94E-01,-1.46E+00,7.01E-02,1.38E-01,FCGR3A-mediated IL10 synthesis
R-HSA-9692914,,86,-1.21E-01,-1.47E+00,7.29E-02,1.42E-01,SARS-CoV-1-host interactions
R-HSA-9701192,,20,-2.60E-01,-1.47E+00,7.36E-02,1.42E-01,Defective HDR through Homologous Recombination (HRR) due to BRCA1 loss-of-function
R-HSA-9701193,,20,-2.60E-01,-1.47E+00,7.36E-02,1.42E-01,Defective HDR through Homologous Recombination (HRR) due to PALB2 loss of function
R-HSA-9704331,,20,-2.60E-01,-1.47E+00,7.36E-02,1.42E-01,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function
R-HSA-9704646,,20,-2.60E-01,-1.47E+00,7.36E-02,1.42E-01,Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function
R-HSA-9709603,,20,-2.60E-01,-1.47E+00,7.36E-02,1.42E-01,Impaired BRCA2 binding to PALB2
R-HSA-2995383,,19,-2.63E-01,-1.46E+00,7.57E-02,1.46E-01,Initiation of Nuclear Envelope (NE) Reformation
R-HSA-6782135,,62,-1.40E-01,-1.44E+00,7.63E-02,1.46E-01,Dual incision in TC-NER
R-HSA-2871837,,75,-1.24E-01,-1.41E+00,7.78E-02,1.48E-01,FCERI mediated NF-kB activation
R-HSA-9675135,,43,-1.70E-01,-1.44E+00,7.85E-02,1.49E-01,Diseases of DNA repair
R-HSA-75893,,45,-1.64E-01,-1.43E+00,7.95E-02,1.50E-01,TNF signaling
R-HSA-380108,,31,-2.04E-01,-1.46E+00,8.11E-02,1.52E-01,Chemokine receptors bind chemokines
R-HSA-983189,,39,-1.75E-01,-1.42E+00,8.10E-02,1.52E-01,Kinesins
R-HSA-174414,,19,-2.60E-01,-1.44E+00,8.19E-02,1.53E-01,Processive synthesis on the C-strand of the telomere
R-HSA-186763,,29,-2.08E-01,-1.43E+00,8.33E-02,1.55E-01,Downstream signal transduction
R-HSA-445989,,41,-1.71E-01,-1.41E+00,8.60E-02,1.60E-01,TAK1-dependent IKK and NF-kappa-B activation  
R-HSA-5663213,,34,-1.87E-01,-1.41E+00,8.61E-02,1.60E-01,RHO GTPases Activate WASPs and WAVEs
R-HSA-76061,,28,-2.10E-01,-1.42E+00,8.67E-02,1.60E-01,RNA Polymerase III Transcription Initiation From Type 1 Promoter
R-HSA-9662851,,61,-1.39E-01,-1.41E+00,8.72E-02,1.61E-01,Anti-inflammatory response favouring Leishmania parasite infection
R-HSA-9664433,,61,-1.39E-01,-1.41E+00,8.72E-02,1.61E-01,Leishmania parasite growth and survival
R-HSA-5607761,,55,-1.46E-01,-1.40E+00,8.80E-02,1.61E-01,Dectin-1 mediated noncanonical NF-kB signaling
R-HSA-9709570,,29,-2.05E-01,-1.42E+00,8.90E-02,1.62E-01,Impaired BRCA2 binding to RAD51
R-HSA-8948751,,62,-1.37E-01,-1.41E+00,8.88E-02,1.62E-01,Regulation of PTEN stability and activity
R-HSA-168638,,36,-1.80E-01,-1.40E+00,8.99E-02,1.63E-01,NOD1/2 Signaling Pathway
R-HSA-2565942,,77,-1.18E-01,-1.35E+00,9.31E-02,1.68E-01,Regulation of PLK1 Activity at G2/M Transition
R-HSA-5632684,,75,-1.20E-01,-1.37E+00,9.73E-02,1.73E-01,Hedgehog 'on' state
R-HSA-5620916,,17,-2.67E-01,-1.40E+00,9.83E-02,1.74E-01,VxPx cargo-targeting to cilium
R-HSA-9758274,,18,-2.58E-01,-1.39E+00,9.79E-02,1.74E-01,Regulation of NF-kappa B signaling
R-HSA-168643,,55,-1.40E-01,-1.34E+00,1.05E-01,1.84E-01,"Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways"
R-HSA-5676590,,54,-1.42E-01,-1.35E+00,1.06E-01,1.85E-01,NIK-->noncanonical NF-kB signaling
R-HSA-9670095,,19,-2.49E-01,-1.38E+00,1.07E-01,1.86E-01,Inhibition of DNA recombination at telomere
R-HSA-4086400,,83,-1.13E-01,-1.38E+00,1.08E-01,1.87E-01,PCP/CE pathway
R-HSA-68875,,76,-1.16E-01,-1.32E+00,1.09E-01,1.88E-01,Mitotic Prophase
R-HSA-5696395,,40,-1.64E-01,-1.34E+00,1.13E-01,1.95E-01,Formation of Incision Complex in GG-NER
R-HSA-76066,,27,-2.05E-01,-1.36E+00,1.15E-01,1.98E-01,RNA Polymerase III Transcription Initiation From Type 2 Promoter
R-HSA-110314,,30,-1.93E-01,-1.36E+00,1.18E-01,2.02E-01,Recognition of DNA damage by PCNA-containing replication complex
R-HSA-5685938,,32,-1.86E-01,-1.35E+00,1.21E-01,2.05E-01,HDR through Single Strand Annealing (SSA)
R-HSA-5619115,,126,-8.73E-02,-1.29E+00,1.23E-01,2.08E-01,Disorders of transmembrane transporters
R-HSA-450513,,17,-2.57E-01,-1.35E+00,1.24E-01,2.09E-01,"Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA"
R-HSA-8866654,,42,-1.57E-01,-1.32E+00,1.25E-01,2.10E-01,E3 ubiquitin ligases ubiquitinate target proteins
R-HSA-4608870,,58,-1.33E-01,-1.31E+00,1.32E-01,2.20E-01,Asymmetric localization of PCP proteins
R-HSA-9022692,,26,-2.02E-01,-1.32E+00,1.34E-01,2.21E-01,Regulation of MECP2 expression and activity
R-HSA-2151201,,50,-1.41E-01,-1.29E+00,1.33E-01,2.21E-01,Transcriptional activation of mitochondrial biogenesis
R-HSA-427389,,15,-2.71E-01,-1.33E+00,1.35E-01,2.23E-01,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression
R-HSA-5601884,,19,-2.37E-01,-1.32E+00,1.42E-01,2.34E-01,PIWI-interacting RNA (piRNA) biogenesis
R-HSA-9645723,,40,-1.59E-01,-1.30E+00,1.43E-01,2.34E-01,Diseases of programmed cell death
R-HSA-8854214,,42,-1.52E-01,-1.28E+00,1.44E-01,2.35E-01,TBC/RABGAPs
R-HSA-174437,,17,-2.47E-01,-1.29E+00,1.49E-01,2.41E-01,Removal of the Flap Intermediate from the C-strand
R-HSA-202733,,99,-9.65E-02,-1.24E+00,1.49E-01,2.41E-01,Cell surface interactions at the vascular wall
R-HSA-3214815,,32,-1.79E-01,-1.30E+00,1.52E-01,2.44E-01,HDACs deacetylate histones
R-HSA-70263,,27,-1.93E-01,-1.28E+00,1.58E-01,2.53E-01,Gluconeogenesis
R-HSA-8856688,,109,-9.58E-02,-1.29E+00,1.61E-01,2.56E-01,Golgi-to-ER retrograde transport
R-HSA-381042,,30,-1.80E-01,-1.27E+00,1.61E-01,2.57E-01,PERK regulates gene expression
R-HSA-5696400,,38,-1.59E-01,-1.27E+00,1.62E-01,2.58E-01,Dual Incision in GG-NER
R-HSA-391251,,71,-1.10E-01,-1.22E+00,1.78E-01,2.76E-01,Protein folding
R-HSA-9711123,,170,-7.39E-02,-1.25E+00,1.78E-01,2.76E-01,Cellular response to chemical stress
R-HSA-9705462,,22,-2.11E-01,-1.26E+00,1.79E-01,2.77E-01,Inactivation of CSF3 (G-CSF) signaling
R-HSA-114604,,31,-1.73E-01,-1.24E+00,1.82E-01,2.79E-01,GPVI-mediated activation cascade
R-HSA-1362277,,18,-2.30E-01,-1.24E+00,1.89E-01,2.85E-01,Transcription of E2F targets under negative control by DREAM complex
R-HSA-2173782,,28,-1.82E-01,-1.23E+00,1.89E-01,2.85E-01,Binding and Uptake of Ligands by Scavenger Receptors
R-HSA-9696264,,37,-1.55E-01,-1.22E+00,1.89E-01,2.85E-01,RND3 GTPase cycle
R-HSA-9674555,,27,-1.86E-01,-1.24E+00,1.90E-01,2.86E-01,Signaling by CSF3 (G-CSF)
R-HSA-5357956,,27,-1.85E-01,-1.23E+00,1.91E-01,2.88E-01,TNFR1-induced NFkappaB signaling pathway
R-HSA-9679191,,88,-9.87E-02,-1.21E+00,1.92E-01,2.88E-01,Potential therapeutics for SARS
R-HSA-6811436,,39,-1.51E-01,-1.22E+00,1.93E-01,2.89E-01,COPI-independent Golgi-to-ER retrograde traffic
R-HSA-912631,,22,-2.08E-01,-1.24E+00,1.94E-01,2.90E-01,Regulation of signaling by CBL
R-HSA-6783783,,34,-1.62E-01,-1.22E+00,1.96E-01,2.90E-01,Interleukin-10 signaling
R-HSA-164938,,20,-2.18E-01,-1.24E+00,1.99E-01,2.93E-01,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters
R-HSA-5696397,,25,-1.89E-01,-1.21E+00,2.03E-01,2.96E-01,Gap-filling DNA repair synthesis and ligation in GG-NER
R-HSA-72187,,54,-1.25E-01,-1.19E+00,2.03E-01,2.97E-01,mRNA 3'-end processing
R-HSA-937072,,16,-2.40E-01,-1.22E+00,2.07E-01,2.99E-01,TRAF6-mediated induction of TAK1 complex within TLR4 complex
R-HSA-8853884,,33,-1.63E-01,-1.21E+00,2.11E-01,3.01E-01,Transcriptional Regulation by VENTX
R-HSA-2029480,,80,-1.01E-01,-1.20E+00,2.11E-01,3.01E-01,Fcgamma receptor (FCGR) dependent phagocytosis
R-HSA-6811442,,171,-7.12E-02,-1.20E+00,2.14E-01,3.03E-01,Intra-Golgi and retrograde Golgi-to-ER traffic
R-HSA-9607240,,37,-1.50E-01,-1.19E+00,2.14E-01,3.03E-01,FLT3 Signaling
R-HSA-5607764,,95,-9.16E-02,-1.17E+00,2.15E-01,3.04E-01,CLEC7A (Dectin-1) signaling
R-HSA-983695,,30,-1.69E-01,-1.19E+00,2.21E-01,3.11E-01,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
R-HSA-5603041,,15,-2.44E-01,-1.20E+00,2.24E-01,3.14E-01,IRAK4 deficiency (TLR2/4)
R-HSA-1632852,,110,-8.81E-02,-1.20E+00,2.28E-01,3.19E-01,Macroautophagy
R-HSA-77595,,20,-2.12E-01,-1.20E+00,2.32E-01,3.22E-01,Processing of Intronless Pre-mRNAs
R-HSA-9020702,,104,-8.96E-02,-1.18E+00,2.39E-01,3.30E-01,Interleukin-1 signaling
R-HSA-5357905,,36,-1.50E-01,-1.17E+00,2.41E-01,3.32E-01,Regulation of TNFR1 signaling
R-HSA-912526,,20,-2.08E-01,-1.18E+00,2.42E-01,3.33E-01,Interleukin receptor SHC signaling
R-HSA-113510,,21,-2.02E-01,-1.17E+00,2.44E-01,3.35E-01,E2F mediated regulation of DNA replication
R-HSA-2022090,,50,-1.25E-01,-1.14E+00,2.46E-01,3.37E-01,Assembly of collagen fibrils and other multimeric structures
R-HSA-9615017,,18,-2.16E-01,-1.16E+00,2.47E-01,3.37E-01,"FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes"
R-HSA-5610787,,94,-9.10E-02,-1.15E+00,2.52E-01,3.41E-01,Hedgehog 'off' state
R-HSA-9748787,,20,-2.06E-01,-1.16E+00,2.54E-01,3.43E-01,Azathioprine ADME
R-HSA-8982491,,24,-1.84E-01,-1.15E+00,2.64E-01,3.51E-01,Glycogen metabolism
R-HSA-1296065,,16,-2.22E-01,-1.13E+00,2.85E-01,3.71E-01,Inwardly rectifying K+ channels
R-HSA-5358508,,15,-2.31E-01,-1.14E+00,2.86E-01,3.73E-01,Mismatch Repair
R-HSA-9682385,,27,-1.68E-01,-1.12E+00,2.96E-01,3.81E-01,FLT3 signaling in disease
R-HSA-937041,,23,-1.83E-01,-1.11E+00,2.96E-01,3.81E-01,IKK complex recruitment mediated by RIP1
R-HSA-5223345,,19,-2.00E-01,-1.11E+00,3.05E-01,3.90E-01,Miscellaneous transport and binding events
R-HSA-164952,,27,-1.67E-01,-1.11E+00,3.06E-01,3.91E-01,The role of Nef in HIV-1 replication and disease pathogenesis
R-HSA-9706574,,34,-1.46E-01,-1.10E+00,3.07E-01,3.92E-01,RHOBTB GTPase Cycle
R-HSA-9612973,,121,-7.49E-02,-1.08E+00,3.11E-01,3.94E-01,Autophagy
R-HSA-933542,,21,-1.87E-01,-1.09E+00,3.20E-01,4.02E-01,TRAF6 mediated NF-kB activation
R-HSA-9020591,,36,-1.40E-01,-1.09E+00,3.23E-01,4.03E-01,Interleukin-12 signaling
R-HSA-6807878,,83,-8.91E-02,-1.09E+00,3.23E-01,4.03E-01,COPI-mediated anterograde transport
R-HSA-9013404,,81,-9.04E-02,-1.08E+00,3.24E-01,4.04E-01,RAC2 GTPase cycle
R-HSA-8866427,,15,-2.23E-01,-1.10E+00,3.28E-01,4.07E-01,VLDLR internalisation and degradation
R-HSA-1500620,,43,-1.27E-01,-1.08E+00,3.35E-01,4.13E-01,Meiosis
R-HSA-9668328,,18,-1.99E-01,-1.07E+00,3.35E-01,4.13E-01,Sealing of the nuclear envelope (NE) by ESCRT-III
R-HSA-9663891,,63,-1.03E-01,-1.07E+00,3.36E-01,4.14E-01,Selective autophagy
R-HSA-6804756,,82,-9.02E-02,-1.08E+00,3.39E-01,4.14E-01,Regulation of TP53 Activity through Phosphorylation
R-HSA-5620912,,85,-8.67E-02,-1.06E+00,3.39E-01,4.14E-01,Anchoring of the basal body to the plasma membrane
R-HSA-1362300,,16,-2.12E-01,-1.08E+00,3.46E-01,4.20E-01,Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
R-HSA-1660516,,16,-2.12E-01,-1.08E+00,3.47E-01,4.21E-01,Synthesis of PIPs at the early endosome membrane
R-HSA-111471,,18,-1.96E-01,-1.06E+00,3.53E-01,4.25E-01,Apoptotic factor-mediated response
R-HSA-110328,,15,-2.17E-01,-1.07E+00,3.57E-01,4.27E-01,Recognition and association of DNA glycosylase with site containing an affected pyrimidine
R-HSA-110329,,15,-2.17E-01,-1.07E+00,3.57E-01,4.27E-01,Cleavage of the damaged pyrimidine 
R-HSA-73928,,15,-2.17E-01,-1.07E+00,3.57E-01,4.27E-01,Depyrimidination
R-HSA-5693606,,37,-1.35E-01,-1.06E+00,3.57E-01,4.27E-01,DNA Double Strand Break Response
R-HSA-8956321,,19,-1.92E-01,-1.07E+00,3.58E-01,4.27E-01,Nucleotide salvage
R-HSA-202424,,87,-8.67E-02,-1.07E+00,3.60E-01,4.28E-01,Downstream TCR signaling
R-HSA-390466,,65,-1.01E-01,-1.06E+00,3.60E-01,4.28E-01,Chaperonin-mediated protein folding
R-HSA-8878166,,104,-8.04E-02,-1.06E+00,3.64E-01,4.30E-01,Transcriptional regulation by RUNX2
R-HSA-352230,,22,-1.78E-01,-1.06E+00,3.64E-01,4.30E-01,Amino acid transport across the plasma membrane
R-HSA-74158,,41,-1.28E-01,-1.06E+00,3.63E-01,4.30E-01,RNA Polymerase III Transcription
R-HSA-749476,,41,-1.28E-01,-1.06E+00,3.63E-01,4.30E-01,RNA Polymerase III Abortive And Retractive Initiation
R-HSA-917729,,27,-1.59E-01,-1.06E+00,3.66E-01,4.31E-01,Endosomal Sorting Complex Required For Transport (ESCRT)
R-HSA-3108214,,70,-9.69E-02,-1.06E+00,3.66E-01,4.31E-01,SUMOylation of DNA damage response and repair proteins
R-HSA-8876384,,18,-1.94E-01,-1.04E+00,3.67E-01,4.32E-01,Listeria monocytogenes entry into host cells
R-HSA-8878159,,91,-8.48E-02,-1.06E+00,3.69E-01,4.32E-01,Transcriptional regulation by RUNX3
R-HSA-8950505,,31,-1.47E-01,-1.05E+00,3.71E-01,4.32E-01,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation
R-HSA-6814122,,25,-1.65E-01,-1.05E+00,3.71E-01,4.32E-01,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
R-HSA-9669938,,20,-1.86E-01,-1.05E+00,3.71E-01,4.32E-01,Signaling by KIT in disease
R-HSA-9670439,,20,-1.86E-01,-1.05E+00,3.71E-01,4.32E-01,"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants"
R-HSA-9717207,,16,-2.07E-01,-1.05E+00,3.79E-01,4.39E-01,"Sensory perception of sweet, bitter, and umami (glutamate) taste"
R-HSA-5357801,,181,-5.78E-02,-1.05E+00,3.85E-01,4.44E-01,Programmed Cell Death
R-HSA-450385,,17,-1.98E-01,-1.04E+00,3.87E-01,4.45E-01,Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
R-HSA-9035034,,40,-1.27E-01,-1.03E+00,3.90E-01,4.47E-01,RHOF GTPase cycle
R-HSA-9725371,,18,-1.89E-01,-1.02E+00,3.97E-01,4.51E-01,Nuclear events stimulated by ALK signaling in cancer
R-HSA-912446,,18,-1.88E-01,-1.01E+00,4.06E-01,4.60E-01,Meiotic recombination
R-HSA-9635486,,23,-1.68E-01,-1.02E+00,4.07E-01,4.61E-01,Infection with Mycobacterium tuberculosis
R-HSA-9675126,,36,-1.31E-01,-1.02E+00,4.14E-01,4.63E-01,Diseases of mitotic cell cycle
R-HSA-110320,,17,-1.93E-01,-1.01E+00,4.14E-01,4.63E-01,Translesion Synthesis by POLH
R-HSA-5693565,,36,-1.31E-01,-1.02E+00,4.18E-01,4.65E-01,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
R-HSA-9703465,,19,-1.84E-01,-1.02E+00,4.21E-01,4.66E-01,Signaling by FLT3 fusion proteins
R-HSA-6804760,,16,-1.99E-01,-1.01E+00,4.29E-01,4.72E-01,Regulation of TP53 Activity through Methylation
R-HSA-379724,,23,-1.63E-01,-9.97E-01,4.44E-01,4.83E-01,tRNA Aminoacylation
R-HSA-1660514,,15,-2.02E-01,-9.95E-01,4.48E-01,4.85E-01,Synthesis of PIPs at the Golgi membrane
R-HSA-451927,,34,-1.32E-01,-9.91E-01,4.48E-01,4.85E-01,Interleukin-2 family signaling
R-HSA-429947,,19,-1.78E-01,-9.89E-01,4.51E-01,4.88E-01,Deadenylation of mRNA
R-HSA-9687139,,35,-1.29E-01,-9.89E-01,4.52E-01,4.88E-01,Aberrant regulation of mitotic cell cycle due to RB1 defects
R-HSA-6811434,,77,-8.86E-02,-1.01E+00,4.53E-01,4.88E-01,COPI-dependent Golgi-to-ER retrograde traffic
R-HSA-8978934,,19,-1.78E-01,-9.85E-01,4.56E-01,4.89E-01,Metabolism of cofactors
R-HSA-201556,,24,-1.56E-01,-9.77E-01,4.72E-01,5.00E-01,Signaling by ALK
R-HSA-162588,,24,-1.55E-01,-9.70E-01,4.83E-01,5.06E-01,Budding and maturation of HIV virion
R-HSA-9637690,,20,-1.71E-01,-9.66E-01,4.80E-01,5.06E-01,Response of Mtb to phagocytosis
R-HSA-2559586,,25,-1.51E-01,-9.65E-01,4.84E-01,5.06E-01,DNA Damage/Telomere Stress Induced Senescence
R-HSA-3299685,,32,-1.32E-01,-9.61E-01,4.86E-01,5.07E-01,Detoxification of Reactive Oxygen Species
R-HSA-8955332,,22,-1.60E-01,-9.52E-01,4.92E-01,5.10E-01,Carboxyterminal post-translational modifications of tubulin
R-HSA-73780,,18,-1.78E-01,-9.56E-01,4.97E-01,5.12E-01,RNA Polymerase III Chain Elongation
R-HSA-9013422,,23,-1.56E-01,-9.54E-01,5.01E-01,5.14E-01,RHOBTB1 GTPase cycle
R-HSA-9634597,,30,-1.34E-01,-9.40E-01,5.13E-01,5.22E-01,GPER1 signaling
R-HSA-9648002,,22,-1.57E-01,-9.37E-01,5.17E-01,5.26E-01,RAS processing
R-HSA-380994,,25,-1.47E-01,-9.40E-01,5.19E-01,5.26E-01,ATF4 activates genes in response to endoplasmic reticulum  stress
R-HSA-163560,,15,-1.87E-01,-9.23E-01,5.49E-01,5.43E-01,Triglyceride catabolism
R-HSA-9619483,,17,-1.75E-01,-9.17E-01,5.56E-01,5.45E-01,Activation of AMPK downstream of NMDARs
R-HSA-5656121,,17,-1.75E-01,-9.17E-01,5.56E-01,5.45E-01,Translesion synthesis by POLI
R-HSA-5654738,,58,-9.39E-02,-9.24E-01,5.61E-01,5.49E-01,Signaling by FGFR2
R-HSA-450604,,17,-1.74E-01,-9.11E-01,5.66E-01,5.49E-01,KSRP (KHSRP) binds and destabilizes mRNA
R-HSA-203927,,20,-1.60E-01,-9.06E-01,5.67E-01,5.50E-01,MicroRNA (miRNA) biogenesis
R-HSA-379726,,17,-1.70E-01,-8.92E-01,5.92E-01,5.69E-01,Mitochondrial tRNA aminoacylation
R-HSA-5693571,,29,-1.29E-01,-8.92E-01,5.91E-01,5.69E-01,Nonhomologous End-Joining (NHEJ)
R-HSA-76009,,27,-1.34E-01,-8.91E-01,5.97E-01,5.69E-01,Platelet Aggregation (Plug Formation)
R-HSA-6782315,,33,-1.20E-01,-8.88E-01,5.97E-01,5.69E-01,tRNA modification in the nucleus and cytosol
R-HSA-5621481,,121,-6.20E-02,-8.92E-01,6.02E-01,5.71E-01,C-type lectin receptors (CLRs)
R-HSA-168927,,19,-1.60E-01,-8.86E-01,6.02E-01,5.71E-01,"TICAM1, RIP1-mediated IKK complex recruitment"
R-HSA-9703648,,15,-1.78E-01,-8.75E-01,6.13E-01,5.75E-01,Signaling by FLT3 ITD and TKD mutants
R-HSA-983231,,105,-6.72E-02,-8.87E-01,6.19E-01,5.77E-01,Factors involved in megakaryocyte development and platelet production
R-HSA-1433557,,41,-1.07E-01,-8.84E-01,6.23E-01,5.78E-01,Signaling by SCF-KIT
R-HSA-5633007,,141,-5.68E-02,-9.07E-01,6.32E-01,5.85E-01,Regulation of TP53 Activity
R-HSA-3000170,,26,-1.32E-01,-8.64E-01,6.32E-01,5.85E-01,Syndecan interactions
R-HSA-2173796,,36,-1.11E-01,-8.62E-01,6.40E-01,5.88E-01,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
R-HSA-2173793,,50,-9.73E-02,-8.85E-01,6.43E-01,5.90E-01,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer
R-HSA-447115,,42,-1.02E-01,-8.62E-01,6.51E-01,5.95E-01,Interleukin-12 family signaling
R-HSA-525793,,19,-1.53E-01,-8.51E-01,6.55E-01,5.95E-01,Myogenesis
R-HSA-1592230,,69,-8.02E-02,-8.72E-01,6.65E-01,6.02E-01,Mitochondrial biogenesis
R-HSA-9658195,,138,-5.48E-02,-8.63E-01,6.67E-01,6.03E-01,Leishmania infection
R-HSA-9660821,,29,-1.22E-01,-8.41E-01,6.78E-01,6.08E-01,ADORA2B mediated anti-inflammatory cytokines production
R-HSA-1169408,,66,-8.05E-02,-8.50E-01,6.84E-01,6.10E-01,ISG15 antiviral mechanism
R-HSA-6804114,,17,-1.59E-01,-8.33E-01,6.87E-01,6.11E-01,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
R-HSA-1839126,,20,-1.47E-01,-8.33E-01,6.88E-01,6.11E-01,FGFR2 mutant receptor activation
R-HSA-110312,,16,-1.62E-01,-8.21E-01,6.93E-01,6.13E-01,Translesion synthesis by REV1
R-HSA-9013420,,39,-1.03E-01,-8.35E-01,6.98E-01,6.17E-01,RHOU GTPase cycle
R-HSA-2644602,,55,-8.55E-02,-8.19E-01,7.19E-01,6.25E-01,Signaling by NOTCH1 PEST Domain Mutants in Cancer
R-HSA-2644603,,55,-8.55E-02,-8.19E-01,7.19E-01,6.25E-01,Signaling by NOTCH1 in Cancer
R-HSA-2644606,,55,-8.55E-02,-8.19E-01,7.19E-01,6.25E-01,Constitutive Signaling by NOTCH1 PEST Domain Mutants
R-HSA-2894858,,55,-8.55E-02,-8.19E-01,7.19E-01,6.25E-01,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer
R-HSA-2894862,,55,-8.55E-02,-8.19E-01,7.19E-01,6.25E-01,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
R-HSA-2990846,,157,-4.97E-02,-8.30E-01,7.27E-01,6.27E-01,SUMOylation
R-HSA-73893,,45,-9.38E-02,-8.18E-01,7.35E-01,6.29E-01,DNA Damage Bypass
R-HSA-354192,,24,-1.28E-01,-8.01E-01,7.33E-01,6.29E-01,Integrin signaling
R-HSA-5213460,,27,-1.18E-01,-7.85E-01,7.50E-01,6.40E-01,RIPK1-mediated regulated necrosis
R-HSA-5675482,,27,-1.18E-01,-7.85E-01,7.50E-01,6.40E-01,Regulation of necroptotic cell death
R-HSA-6791312,,42,-9.40E-02,-7.91E-01,7.55E-01,6.42E-01,TP53 Regulates Transcription of Cell Cycle Genes
R-HSA-844456,,15,-1.58E-01,-7.78E-01,7.55E-01,6.42E-01,The NLRP3 inflammasome
R-HSA-418346,,59,-8.03E-02,-8.01E-01,7.64E-01,6.46E-01,Platelet homeostasis
R-HSA-6806003,,34,-1.03E-01,-7.77E-01,7.65E-01,6.47E-01,Regulation of TP53 Expression and Degradation
R-HSA-110313,,36,-1.00E-01,-7.80E-01,7.72E-01,6.49E-01,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template
R-HSA-1445148,,60,-7.86E-02,-7.90E-01,7.80E-01,6.54E-01,Translocation of SLC2A4 (GLUT4) to the plasma membrane
R-HSA-8851708,,19,-1.36E-01,-7.55E-01,7.85E-01,6.57E-01,Signaling by FGFR2 IIIa TM
R-HSA-2682334,,83,-6.29E-02,-7.68E-01,7.89E-01,6.57E-01,EPH-Ephrin signaling
R-HSA-9735871,,15,-1.52E-01,-7.48E-01,7.88E-01,6.57E-01,SARS-CoV-1 targets host intracellular signalling and regulatory pathways
R-HSA-450302,,23,-1.23E-01,-7.49E-01,8.04E-01,6.63E-01,activated TAK1 mediates p38 MAPK activation
R-HSA-2559585,,30,-1.06E-01,-7.48E-01,8.06E-01,6.63E-01,Oncogene Induced Senescence
R-HSA-69231,,46,-8.58E-02,-7.59E-01,8.30E-01,6.75E-01,Cyclin D associated events in G1
R-HSA-69236,,46,-8.58E-02,-7.59E-01,8.30E-01,6.75E-01,G1 Phase
R-HSA-5628897,,73,-6.73E-02,-7.55E-01,8.31E-01,6.75E-01,TP53 Regulates Metabolic Genes
R-HSA-9678108,,129,-4.98E-02,-7.61E-01,8.38E-01,6.78E-01,SARS-CoV-1 Infection
R-HSA-9006335,,24,-1.15E-01,-7.21E-01,8.41E-01,6.78E-01,Signaling by Erythropoietin
R-HSA-622312,,20,-1.27E-01,-7.20E-01,8.40E-01,6.78E-01,Inflammasomes
R-HSA-109581,,157,-4.30E-02,-7.18E-01,8.48E-01,6.79E-01,Apoptosis
R-HSA-9029569,,28,-1.06E-01,-7.19E-01,8.54E-01,6.79E-01,NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
R-HSA-977444,,22,-1.19E-01,-7.09E-01,8.60E-01,6.80E-01,GABA B receptor activation
R-HSA-991365,,22,-1.19E-01,-7.09E-01,8.60E-01,6.80E-01,Activation of GABAB receptors
R-HSA-9013405,,50,-7.76E-02,-7.06E-01,8.90E-01,6.89E-01,RHOD GTPase cycle
R-HSA-3108232,,151,-4.13E-02,-6.81E-01,8.92E-01,6.89E-01,SUMO E3 ligases SUMOylate target proteins
R-HSA-977225,,36,-8.79E-02,-6.84E-01,8.97E-01,6.91E-01,Amyloid fiber formation
R-HSA-9692916,,36,-8.37E-02,-6.51E-01,9.27E-01,6.95E-01,SARS-CoV-1 activates/modulates innate immune responses
R-HSA-6804757,,33,-8.76E-02,-6.50E-01,9.23E-01,6.95E-01,Regulation of TP53 Degradation
R-HSA-5689896,,37,-8.15E-02,-6.43E-01,9.30E-01,6.95E-01,Ovarian tumor domain proteases
R-HSA-9671555,,20,-1.12E-01,-6.33E-01,9.39E-01,6.97E-01,Signaling by PDGFR in disease
R-HSA-1912420,,16,-1.22E-01,-6.22E-01,9.39E-01,6.97E-01,Pre-NOTCH Processing in Golgi
R-HSA-4655427,,16,-1.22E-01,-6.20E-01,9.39E-01,6.97E-01,SUMOylation of DNA methylation proteins
R-HSA-140534,,15,-1.24E-01,-6.10E-01,9.40E-01,6.97E-01,Caspase activation via Death Receptors in the presence of ligand
R-HSA-3928665,,45,-7.30E-02,-6.37E-01,9.44E-01,6.99E-01,EPH-ephrin mediated repulsion of cells
R-HSA-977443,,24,-9.80E-02,-6.13E-01,9.48E-01,7.00E-01,GABA receptor activation
R-HSA-5260271,,28,-8.91E-02,-6.03E-01,9.62E-01,7.02E-01,Diseases of Immune System
R-HSA-5602358,,28,-8.91E-02,-6.03E-01,9.62E-01,7.02E-01,Diseases associated with the TLR signaling cascade
R-HSA-9734009,,21,-1.01E-01,-5.88E-01,9.60E-01,7.02E-01,Defective Intrinsic Pathway for Apoptosis
R-HSA-5656169,,31,-8.18E-02,-5.85E-01,9.72E-01,7.05E-01,Termination of translesion DNA synthesis
R-HSA-9013423,,84,-4.85E-02,-5.93E-01,9.74E-01,7.06E-01,RAC3 GTPase cycle
R-HSA-936964,,17,-1.07E-01,-5.59E-01,9.75E-01,7.06E-01,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
R-HSA-2173795,,29,-8.09E-02,-5.58E-01,9.78E-01,7.06E-01,Downregulation of SMAD2/3:SMAD4 transcriptional activity
R-HSA-450321,,22,-9.28E-02,-5.54E-01,9.83E-01,7.06E-01,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1
R-HSA-5655862,,17,-1.02E-01,-5.33E-01,9.87E-01,7.06E-01,Translesion synthesis by POLK
R-HSA-5621575,,20,-9.39E-02,-5.31E-01,9.88E-01,7.06E-01,CD209 (DC-SIGN) signaling
R-HSA-2979096,,21,-8.91E-02,-5.19E-01,9.90E-01,7.06E-01,NOTCH2 Activation and Transmission of Signal to the Nucleus
R-HSA-418360,,19,-9.18E-02,-5.09E-01,9.93E-01,7.06E-01,Platelet calcium homeostasis
R-HSA-171319,,19,-9.10E-02,-5.05E-01,9.94E-01,7.06E-01,Telomere Extension By Telomerase
